microdosing glp-1 perimenopause for Perimenopause: Why Lower Doses Might Be Better GLP-1 Microdosing During Menopause: Is
Description
We are going to uncap our needle and, if youre doing this on yourself, youre going to kind of pinch up a little bit of skin in between your fingers
Side effects generally scale with dose increases
It is not a GLP-1, it doesnt affect insulin, and it doesnt slow gastric emptying
Third, insufficient information on medication histories and confounding by indication limits differentiation between drug effects and underlying disease progression and complications
Potential Ozempic advantage: Larger cardiovascular event reduction in SUSTAIN 6 (26%) versus REWIND (12%), though study populations differed
